Navigation Links
Varian Medical Systems Adds RapidArc(R) and Image Guidance to New Low Energy Treatment Platform for Radiation Therapy in International Cancer Clinics
Date:8/30/2009

MAASTRICHT, The Netherlands, Aug. 31 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) is introducing the world's first low-energy radiotherapy system with image-guidance and RapidArc treatment capabilities for international cancer clinics. Varian's UNIQUE(TM) radiotherapy system is expected to make advanced care more affordable and more widely available to cancer patients around the world.

"This package is truly a unique offering for international markets," says Dow Wilson, president of Varian's Oncology Systems business. "We have added high-tech image-guidance and arc therapy tools to a low energy platform together with our treatment planning and information management software so that technology for fast, state-of-the-art cancer treatments can be made available to treatment centers at a cost under $2 million. It's in keeping with our mission to save more lives by making proven advanced radiotherapy technology available to people who currently do not have access to it."

The UNIQUE Performance Edition incorporates all the tools needed to easily establish or enhance a clinically effective radiotherapy treatment operation. The UNIQUE* platform's low energy medical linear accelerator incorporates Varian's proven technologies for reliable and consistent dose control, delivery, and beam shaping, into an elegant machine with patient friendly design that is small enough to fit into almost all existing treatment bunkers. The system is ideally equipped for treating cancers of the head and neck, breast, cervix and prostate, which make up the majority of cases in most areas of the world. It will be exhibited for the first time at the 10th Biennial ESTRO Conference on Physics and Radiation Technology taking place here this week.

"It's a comprehensive, cost-effective offering that will provide cancer patients with standard treatments as well as advanced techniques, including intensity modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and RapidArc(R) treatments," said Rolf Staehelin, Varian's European marketing director. "By making UNIQUE available with advanced capabilities developed for our high-energy platforms, we hope to help more clinicians around the world to offer higher standards of care for all of their patients."

Varian will also offer a UNIQUE Power Edition without RapidArc technology or image-guidance software, for centers that prefer to begin with a more basic yet upgradeable platform.

Either package is ideal for treatment centers looking to transition from older cobalt units to modern radiotherapy technology. The small footprint of the UNIQUE accelerator allows it to fit into most small, existing treatment vaults. UNIQUE is not for sale in the U.S., Canada, or Japan.

In addition to the UNIQUE offerings, the Varian booth at ESTRO (Booth No. 240) is showcasing a wide spectrum of new and updated products that improve and simplify the processes of radiotherapy and radiosurgery, including a new version of the Eclipse(TM) radiotherapy treatment planning system, with new features that enhance the product's speed, precision, and clinical flexibility. Varian is also highlighting the widespread clinical implementation of its RapidArc volumetric modulated arc therapy technology, which represents the most successful product introduction in the company's history with more than 180 centers globally treating clinically to date. Prior to the show, Varian held a Users Meeting attended by more than 220 people which focused on the multiple clinical indications for which RapidArc is being routinely utilized at cancer centers around the world.

*UNIQUE(TM) is a works-in-progress and requires country-specific regulatory approval prior to clinical use. UNIQUE(TM) is not for sale in the USA, Canada, or Japan.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068, neil.madle@varian.com

ABOUT VARIAN MEDICAL SYSTEMS

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 79 sales and support offices around the world. For more information, visit http://www.varian.com.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fertility Can Be Preserved in Ovarian Cancer Patients
2. Leading Turkish Hospital Group Selects Varian Equipment for Major Expansion
3. Young early stage ovarian cancer patients can preserve fertility
4. Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
5. Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients
6. Suicide Genes Help Slow Ovarian Tumor Growth in Mice
7. Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth
8. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
9. New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer
10. Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
11. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Christmas in ... creation of published author, Sara Seymour, who lives in Lafayette, Indiana where she works ... sips on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the German ... Germany , has purchased a MRIdian ... Clinic Heidelberg as part of its initiative for MRI-based ... be headed by Medical Director and Professor Jürgen Debus, ... German Cancer Research Center (DKFZ), the Heidelberg Heavy Ion ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: